Henckaerts L - Search Results

1

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.

Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, Norman GL, Altstock RT, Van Steen K, Rutgeerts P, Van Assche G, Vermeire S. Ferrante M, et al. Among authors: henckaerts l. Gut. 2007 Oct;56(10):1394-403. doi: 10.1136/gut.2006.108043. Epub 2007 Apr 24. Gut. 2007. PMID: 17456509 Free PMC article.

2

Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.

Hlavaty T, Pierik M, Henckaerts L, Ferrante M, Joossens S, van Schuerbeek N, Noman M, Rutgeerts P, Vermeire S. Hlavaty T, et al. Among authors: henckaerts l. Aliment Pharmacol Ther. 2005 Oct 1;22(7):613-26. doi: 10.1111/j.1365-2036.2005.02635.x. Aliment Pharmacol Ther. 2005. PMID: 16181301 Free article.

3

Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.

Vermeire S, Pierik M, Hlavaty T, Claessens G, van Schuerbeeck N, Joossens S, Ferrante M, Henckaerts L, Bueno de Mesquita M, Vlietinck R, Rutgeerts P. Vermeire S, et al. Among authors: henckaerts l. Gastroenterology. 2005 Dec;129(6):1845-53. doi: 10.1053/j.gastro.2005.10.006. Gastroenterology. 2005. PMID: 16344053

4

CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis.

Henckaerts L, Fevery J, Van Steenbergen W, Verslype C, Yap P, Nevens F, Roskams T, Libbrecht L, Rutgeerts P, Vermeire S. Henckaerts L, et al. Inflamm Bowel Dis. 2006 Apr;12(4):272-7. doi: 10.1097/01.MIB.0000209790.21737.28. Inflamm Bowel Dis. 2006. PMID: 16633049

5

The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease.

Ferrante M, Pierik M, Henckaerts L, Joossens M, Claes K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, Van Assche G, Vermeire S. Ferrante M, et al. Among authors: henckaerts l. Inflamm Bowel Dis. 2006 Sep;12(9):870-8. doi: 10.1097/01.mib.0000235095.01608.10. Inflamm Bowel Dis. 2006. PMID: 16954806

6

NOD2/CARD15 disease associations other than Crohn's disease.

Henckaerts L, Vermeire S. Henckaerts L, et al. Inflamm Bowel Dis. 2007 Feb;13(2):235-41. doi: 10.1002/ibd.20066. Inflamm Bowel Dis. 2007. PMID: 17206682 Review.

7

Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors.

Hlavaty T, Ferrante M, Henckaerts L, Pierik M, Rutgeerts P, Vermeire S. Hlavaty T, et al. Among authors: henckaerts l. Inflamm Bowel Dis. 2007 Apr;13(4):372-9. doi: 10.1002/ibd.20024. Inflamm Bowel Dis. 2007. PMID: 17206723

8

The RANTES -28 g polymorphism is associated with primary sclerosing cholangitis.

Henckaerts L, Fevery J, Van Steenbergen W, Verslype C, Nevens F, Yap P, Roskams T, Rutgeerts P, Vermeire S. Henckaerts L, et al. Gut. 2007 Jun;56(6):891-2. doi: 10.1136/gut.2006.115329. Gut. 2007. PMID: 17519498 Free PMC article. No abstract available.

9

Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.

Henckaerts L, Pierik M, Joossens M, Ferrante M, Rutgeerts P, Vermeire S. Henckaerts L, et al. Gut. 2007 Nov;56(11):1536-42. doi: 10.1136/gut.2007.125468. Epub 2007 Jun 26. Gut. 2007. PMID: 17595233 Free PMC article.

10

The role of genetics in inflammatory bowel disease.

Henckaerts L, Figueroa C, Vermeire S, Sans M. Henckaerts L, et al. Curr Drug Targets. 2008 May;9(5):361-8. doi: 10.2174/138945008784221161. Curr Drug Targets. 2008. PMID: 18473763 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters